The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 2, 2013, Pages 2496-2508

  Filatova, Alina ^a   Acker, Till ^a   Garvalov, Boyan K ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cancer stem cell; Glioma; Hypoxia inducible factor; Hypoxic niche; Perivascular niche; Tumor associated macrophage

Indexed keywords

ALPHA6 INTEGRIN; BONE MORPHOGENETIC PROTEIN 4; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR VIII; ERYTHROPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6 RECEPTOR ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 128; MICRORNA 326; MICRORNA 34A; MICRORNA 452; MICRORNA 7; NERVE CELL ADHESION MOLECULE L1; NOTCH1 RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PROTEIN KINASE B; RAC1 PROTEIN; SCATTER FACTOR RECEPTOR; SOMATOMEDIN BINDING PROTEIN 2; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN;

CANCER GROWTH; CANCER STEM CELL; CELL FUNCTION; CELL INTERACTION; CELL RENEWAL; CELL TRANSDIFFERENTIATION; ENDOTHELIAL PROGENITOR CELL; GLIOMA STEM CELL; HOMEOSTASIS; HUMAN; HYPOXIC NICHE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; NONHUMAN; PERIVASCULAR NICHE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; STEM CELL NICHE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

BRAIN NEOPLASMS; GLIOMA; HUMANS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84872496776     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.10.008     Document Type: Review

References (211)

1. B.B. Zhou, H. Zhang, M. Damelin, K.G. Geles, J.C. Grindley, and P.B. Dirks Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Nat. Rev. Drug Discov. 8 2009 806 823
2. S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, and J.N. Rich Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
3. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, G. Sette, E. Pilozzi, L.M. Larocca, C. Peschle, and R. De Maria Chemotherapy resistance of glioblastoma stem cells Cell Death Differ. 13 2006 1238 1241
4. A.G. Schepers, H.J. Snippert, D.E. Stange, M. van den Born, J.H. van Es, M. van de Wetering, and H. Clevers Lineage tracing reveals Lgr5 + stem cell activity in mouse intestinal adenomas Science 337 2012 730 735
5. J. Chen, Y. Li, T.S. Yu, R.M. McKay, D.K. Burns, S.G. Kernie, and L.F. Parada A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 2012 522 526
6. G. Driessens, B. Beck, A. Caauwe, B.D. Simons, and C. Blanpain Defining the mode of tumour growth by clonal analysis Nature 488 2012 527 530
7. P.N. Kelly, A. Dakic, J.M. Adams, S.L. Nutt, and A. Strasser Tumor growth need not be driven by rare cancer stem cells Science 317 2007 337
8. J.A. Kennedy, F. Barabe, A.G. Poeppl, J.C. Wang, and J.E. Dick Comment on Tumor growth need not be driven by rare cancer stem cells Science 318 2007 1722 (author reply 1722)
9. C. le Viseur, M. Hotfilder, S. Bomken, K. Wilson, S. Rottgers, A. Schrauder, A. Rosemann, J. Irving, R.W. Stam, L.D. Shultz, J. Harbott, H. Jurgens, M. Schrappe, R. Pieters, and J. Vormoor In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties Cancer Cell 14 2008 47 58
10. E. Quintana, M. Shackleton, M.S. Sabel, D.R. Fullen, T.M. Johnson, and S.J. Morrison Efficient tumour formation by single human melanoma cells Nature 456 2008 593 598
11. R. Chen, M.C. Nishimura, S.M. Bumbaca, S. Kharbanda, W.F. Forrest, I.M. Kasman, J.M. Greve, R.H. Soriano, L.L. Gilmour, C.S. Rivers, Z. Modrusan, S. Nacu, S. Guerrero, K.A. Edgar, J.J. Wallin, K. Lamszus, M. Westphal, S. Heim, C.D. James, S.R. VandenBerg, J.F. Costello, S. Moorefield, C.J. Cowdrey, M. Prados, and H.S. Phillips A hierarchy of self-renewing tumor-initiating cell types in glioblastoma Cancer Cell 17 2010 362 375
12. A. Roesch, M. Fukunaga-Kalabis, E.C. Schmidt, S.E. Zabierowski, P.A. Brafford, A. Vultur, D. Basu, P. Gimotty, T. Vogt, and M. Herlyn A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth Cell 141 2010 583 594
13. J.E. Visvader, and G.J. Lindeman Cancer stem cells: current status and evolving complexities Cell Stem Cell 10 2012 717 728
14. M. Venere, H.A. Fine, P.B. Dirks, and J.N. Rich Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy Glia 59 2011 1148 1154
15. V. Goidts, J. Bageritz, L. Puccio, S. Nakata, M. Zapatka, S. Barbus, G. Toedt, B. Campos, A. Korshunov, S. Momma, E. Van Schaftingen, G. Reifenberger, C. Herold-Mende, P. Lichter, and B. Radlwimmer RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival Oncogene 31 2012 3235 3243
16. S.E. Mir, P.C. De Witt Hamer, P.M. Krawczyk, L. Balaj, A. Claes, J.M. Niers, A.A. Van Tilborg, A.H. Zwinderman, D. Geerts, G.J. Kaspers, W. Peter Vandertop, J. Cloos, B.A. Tannous, P. Wesseling, J.A. Aten, D.P. Noske, C.J. Van Noorden, and T. Wurdinger In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma Cancer Cell 18 2010 244 257
17. S. Seidel, B.K. Garvalov, V. Wirta, L. von Stechow, A. Schänzer, K. Meletis, M. Wolter, D. Sommerlad, A.T. Henze, M. Nistér, G. Reifenberger, J. Lundeberg, J. Frisén, and T. Acker A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2a Brain 133 2010 983 995
18. X. Yan, L. Ma, D. Yi, J.G. Yoon, A. Diercks, G. Foltz, N.D. Price, L.E. Hood, and Q. Tian A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations Proc. Natl. Acad. Sci. U. S. A. 108 2011 1591 1596
19. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco, and A. Vescovi Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res. 64 2004 7011 7021
20. S.K. Singh, I.D. Clarke, M. Terasaki, V.E. Bonn, C. Hawkins, J. Squire, and P.B. Dirks Identification of a cancer stem cell in human brain tumors Cancer Res. 63 2003 5821 5828
21. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, and P.B. Dirks Identification of human brain tumour initiating cells Nature 432 2004 396 401
22. J.C. Hemphill III, W.S. Smith, D.C. Sonne, D. Morabito, and G.T. Manley Relationship between brain tissue oxygen tension and CT perfusion: feasibility and initial results AJNR Am. J. Neuroradiol. 26 2005 1095 1100
23. T. Acker, and H. Acker Cellular oxygen sensing need in CNS function: physiological and pathological implications J. Exp. Biol. 207 2004 3171 3188
24. E.E. Bar, A. Lin, V. Mahairaki, W. Matsui, and C.G. Eberhart Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres Am. J. Pathol. 177 2010 1491 1502
25. S.M. Evans, K.W. Jenkins, W.T. Jenkins, T. Dilling, K.D. Judy, A. Schrlau, A. Judkins, S.M. Hahn, and C.J. Koch Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors Radiat. Res. 170 2008 677 690
26. S.M. Evans, K.D. Judy, I. Dunphy, W.T. Jenkins, W.T. Hwang, P.T. Nelson, R.A. Lustig, K. Jenkins, D.P. Magarelli, S.M. Hahn, R.A. Collins, M.S. Grady, and C.J. Koch Hypoxia is important in the biology and aggression of human glial brain tumors Clin. Cancer Res. 10 2004 8177 8184
27. T. Acker, J. Fandrey, and H. Acker The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases Cardiovasc. Res. 71 2006 195 207
28. G.L. Semenza Hypoxia-inducible factors in physiology and medicine Cell 148 2012 399 408
29. B. Keith, R.S. Johnson, and M.C. Simon HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression Nat. Rev. Cancer 12 2012 9 22
30. G.L. Wang, B.H. Jiang, E.A. Rue, and G.L. Semenza Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc. Natl. Acad. Sci. U. S. A. 92 1995 5510 5514
31. S.M. Wood, J.M. Gleadle, C.W. Pugh, O. Hankinson, and P.J. Ratcliffe The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells J. Biol. Chem. 271 1996 15117 15123
32. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 2001 1337 1340
33. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R. Mole, M. Mukherji, E. Metzen, M.I. Wilson, A. Dhanda, Y.M. Tian, N. Masson, D.L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P.H. Maxwell, C.W. Pugh, C.J. Schofield, and P.J. Ratcliffe C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
34. M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J.M. Asara, W.S. Lane, and W.G. Kaelin Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing Science 292 2001 464 468
35. P. Jaakkola, D.R. Mole, Y.M. Tian, M.I. Wilson, J. Gielbert, S.J. Gaskell, A. Kriegsheim, H.F. Hebestreit, M. Mukherji, C.J. Schofield, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 292 2001 468 472
36. T. Acker, A. Diez-Juan, J. Aragones, M. Tjwa, K. Brusselmans, L. Moons, D. Fukumura, M.P. Moreno-Murciano, J.M. Herbert, A. Burger, J. Riedel, G. Elvert, I. Flamme, P.H. Maxwell, D. Collen, M. Dewerchin, R.K. Jain, K.H. Plate, and P. Carmeliet Genetic evidence for a tumor suppressor role of HIF-2alpha Cancer Cell 8 2005 131 141
37. A.T. Henze, and T. Acker Feedback regulators of hypoxia-inducible factors and their role in cancer biology Cell Cycle 9 2010 2749 2763
38. B. Keith, and M.C. Simon Hypoxia-inducible factors, stem cells, and cancer Cell 129 2007 465 472
39. L. Holmquist, A. Jogi, and S. Pahlman Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells Int. J. Cancer 116 2005 218 225
40. L. Holmquist-Mengelbier, E. Fredlund, T. Lofstedt, R. Noguera, S. Navarro, H. Nilsson, A. Pietras, J. Vallon-Christersson, A. Borg, K. Gradin, L. Poellinger, and S. Pahlman Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype Cancer Cell 10 2006 413 423
41. M.S. Wiesener, H. Turley, W.E. Allen, C. Willam, K.U. Eckardt, K.L. Talks, S.M. Wood, K.C. Gatter, A.L. Harris, C.W. Pugh, P.J. Ratcliffe, and P.H. Maxwell Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha Blood 92 1998 2260 2268
42. Z. Li, S. Bao, Q. Wu, H. Wang, C. Eyler, S. Sathornsumetee, Q. Shi, Y. Cao, J. Lathia, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 2009 501 513
43. A.M. McCord, M. Jamal, U.T. Shankavaram, F.F. Lang, K. Camphausen, and P.J. Tofilon Physiologic oxygen concentration enhances the stem-like properties of CD133 + human glioblastoma cells in vitro Mol. Cancer Res. 7 2009 489 497
44. A. Soeda, M. Park, D. Lee, A. Mintz, A. Androutsellis-Theotokis, R.D. McKay, J. Engh, T. Iwama, T. Kunisada, A.B. Kassam, I.F. Pollack, and D.M. Park Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha Oncogene 28 2009 3949 3959
45. O. Mendez, J. Zavadil, M. Esencay, Y. Lukyanov, D. Santovasi, S.C. Wang, E.W. Newcomb, and D. Zagzag Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres Mol. Cancer 9 2010 133
46. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
47. K.L. Covello, J. Kehler, H. Yu, J.D. Gordan, A.M. Arsham, C.J. Hu, P.A. Labosky, M.C. Simon, and B. Keith HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth Genes Dev. 20 2006 557 570
48. V. Moreno-Manzano, F.J. Rodriguez-Jimenez, J.L. Acena-Bonilla, S. Fustero-Lardies, S. Erceg, J. Dopazo, D. Montaner, M. Stojkovic, and J.M. Sanchez-Puelles FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status J. Biol. Chem. 285 2010 1333 1342
49. J.D. Gordan, J.A. Bertout, C.J. Hu, J.A. Diehl, and M.C. Simon HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity Cancer Cell 11 2007 335 347
50. J.M. Heddleston, Z. Li, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 8 2009 3274 3284
51. J. Mathieu, Z. Zhang, W. Zhou, A.J. Wang, J.M. Heddleston, C.M. Pinna, A. Hubaud, B. Stadler, M. Choi, M. Bar, M. Tewari, A. Liu, R. Vessella, R. Rostomily, D. Born, M. Horwitz, C. Ware, C.A. Blau, M.A. Cleary, J.N. Rich, and H. Ruohola-Baker HIF induces human embryonic stem cell markers in cancer cells Cancer Res. 71 2011 4640 4652
52. J. Chiche, M.C. Brahimi-Horn, and J. Pouyssegur Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer J. Cell Mol. Med. 14 2010 771 794
53. A.B. Hjelmeland, Q. Wu, J.M. Heddleston, G.S. Choudhary, J. MacSwords, J.D. Lathia, R. McLendon, D. Lindner, A. Sloan, and J.N. Rich Acidic stress promotes a glioma stem cell phenotype Cell Death Differ. 18 2011 829 840
54. X. Fan, L. Khaki, T.S. Zhu, M.E. Soules, C.E. Talsma, N. Gul, C. Koh, J. Zhang, Y.M. Li, J. Maciaczyk, G. Nikkhah, F. Dimeco, S. Piccirillo, A.L. Vescovi, and C.G. Eberhart NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts Stem Cells 28 2010 5 16
55. M.V. Gustafsson, X. Zheng, T. Pereira, K. Gradin, S. Jin, J. Lundkvist, J.L. Ruas, L. Poellinger, U. Lendahl, and M. Bondesson Hypoxia requires notch signaling to maintain the undifferentiated cell state Dev. Cell 9 2005 617 628
56. F. Pistollato, E. Rampazzo, L. Persano, S. Abbadi, C. Frasson, L. Denaro, D. D'Avella, D.M. Panchision, A. Della Puppa, R. Scienza, and G. Basso Interaction of hypoxia-inducible factor-1alpha and Notch signaling regulates medulloblastoma precursor proliferation and fate Stem Cells 28 2010 1918 1929
57. S.J. Morrison, M. Csete, A.K. Groves, W. Melega, B. Wold, and D.J. Anderson Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells J. Neurosci. 20 2000 7370 7376
58. L. Studer, M. Csete, S.H. Lee, N. Kabbani, J. Walikonis, B. Wold, and R. McKay Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J. Neurosci. 20 2000 7377 7383
59. C. Calabrese, H. Poppleton, M. Kocak, T.L. Hogg, C. Fuller, B. Hamner, E.Y. Oh, M.W. Gaber, D. Finklestein, M. Allen, A. Frank, I.T. Bayazitov, S.S. Zakharenko, A. Gajjar, A. Davidoff, and R.J. Gilbertson A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
60. K. Christensen, H.D. Schroder, and B.W. Kristensen CD133 + niches and single cells in glioblastoma have different phenotypes J. Neurooncol. 104 2011 129 143
61. K.E. Hovinga, F. Shimizu, R. Wang, G. Panagiotakos, M. Van Der Heijden, H. Moayedpardazi, A.S. Correia, D. Soulet, T. Major, J. Menon, and V. Tabar Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate Stem Cells 28 2010 1019 1029
62. T.S. Zhu, M.A. Costello, C.E. Talsma, C.G. Flack, J.G. Crowley, L.L. Hamm, X. He, S.L. Hervey-Jumper, J.A. Heth, K.M. Muraszko, F. DiMeco, A.L. Vescovi, and X. Fan Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells Cancer Res. 71 2010 6061 6072
63. S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A.B. Hjelmeland, Q. Shi, R.E. McLendon, D.D. Bigner, and J.N. Rich Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res. 66 2006 7843 7848
64. Z.J. Liu, T. Shirakawa, Y. Li, A. Soma, M. Oka, G.P. Dotto, R.M. Fairman, O.C. Velazquez, and M. Herlyn Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis Mol. Cell. Biol. 23 2003 14 25
65. I.B. Lobov, R.A. Renard, N. Papadopoulos, N.W. Gale, G. Thurston, G.D. Yancopoulos, and S.J. Wiegand Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting Proc. Natl. Acad. Sci. U. S. A. 104 2007 3219 3224
66. N. Charles, T. Ozawa, M. Squatrito, A.M. Bleau, C.W. Brennan, D. Hambardzumyan, and E.C. Holland Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells Cell Stem Cell 6 2010 141 152
67. C.E. Eyler, Q. Wu, K. Yan, J.M. MacSwords, D. Chandler-Militello, K.L. Misuraca, J.D. Lathia, M.T. Forrester, J. Lee, J.S. Stamler, S.A. Goldman, M. Bredel, R.E. McLendon, A.E. Sloan, A.B. Hjelmeland, and J.N. Rich Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2 Cell 146 2011 53 66
68. E.E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck, W. Matsui, S. Piccirillo, A.L. Vescovi, F. DiMeco, A. Olivi, and C.G. Eberhart Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma Stem Cells 25 2007 2524 2533
69. V. Clement, P. Sanchez, N. de Tribolet, I. Radovanovic, and A. Ruiz i Altaba, HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity Curr. Biol. 17 2007 165 172
70. J.M. Leonard, H. Ye, C. Wetmore, and L.M. Karnitz Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability J. Cell Biol. 183 2008 385 391
71. I.V. Ulasov, S. Nandi, M. Dey, A.M. Sonabend, and M.S. Lesniak Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy Mol. Med. 17 2011 103 112
72. Q. Xu, X. Yuan, G. Liu, K.L. Black, and J.S. Yu Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas Stem Cells 26 2008 3018 3026
73. O.J. Becher, D. Hambardzumyan, E.I. Fomchenko, H. Momota, L. Mainwaring, A.M. Bleau, A.M. Katz, M. Edgar, A.M. Kenney, C. Cordon-Cardo, R.G. Blasberg, and E.C. Holland Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas Cancer Res. 68 2008 2241 2249
74. J.D. Lathia, J. Gallagher, J.M. Heddleston, J. Wang, C.E. Eyler, J. Macswords, Q. Wu, A. Vasanji, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Integrin alpha 6 regulates glioblastoma stem cells Cell Stem Cell 6 2010 421 432
75. Q. Shen, Y. Wang, E. Kokovay, G. Lin, S.M. Chuang, S.K. Goderie, B. Roysam, and S. Temple Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions Cell Stem Cell 3 2008 289 300
76. D. Hambardzumyan, O.J. Becher, M.K. Rosenblum, P.P. Pandolfi, K. Manova-Todorova, and E.C. Holland PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo Genes Dev. 22 2008 436 448
77. Z. Mirzadeh, F.T. Merkle, M. Soriano-Navarro, J.M. Garcia-Verdugo, and A. Alvarez-Buylla Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain Cell Stem Cell 3 2008 265 278
78. M. Tavazoie, L. Van der Veken, V. Silva-Vargas, M. Louissaint, L. Colonna, B. Zaidi, J.M. Garcia-Verdugo, and F. Doetsch A specialized vascular niche for adult neural stem cells Cell Stem Cell 3 2008 279 288
79. N. Oka, A. Soeda, A. Inagaki, M. Onodera, H. Maruyama, A. Hara, T. Kunisada, H. Mori, and T. Iwama VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells Biochem. Biophys. Res. Commun. 360 2007 553 559
80. Y.F. Ping, X.H. Yao, J.Y. Jiang, L.T. Zhao, S.C. Yu, T. Jiang, M.C. Lin, J.H. Chen, B. Wang, R. Zhang, Y.H. Cui, C. Qian, J. Wang, and X.W. Bian The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling J. Pathol. 224 2011 344 354
81. C. Folkins, Y. Shaked, S. Man, T. Tang, C.R. Lee, Z. Zhu, R.M. Hoffman, and R.S. Kerbel Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1 Cancer Res. 69 2009 7243 7251
82. L. Ricci-Vitiani, R. Pallini, M. Biffoni, M. Todaro, G. Invernici, T. Cenci, G. Maira, E.A. Parati, G. Stassi, L.M. Larocca, and R. De Maria Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 468 2010 824 828
83. R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Geber, B. Fligelman, M. Leversha, C. Brennan, and V. Tabar Glioblastoma stem-like cells give rise to tumour endothelium Nature 468 2010 829 833
84. P. Hamerlik, J.D. Lathia, R. Rasmussen, Q. Wu, J. Bartkova, M. Lee, P. Moudry, J. Bartek Jr., W. Fischer, J. Lukas, J.N. Rich, and J. Bartek Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth J. Exp. Med. 209 2012 507 520
85. R. Du, K.V. Lu, C. Petritsch, P. Liu, R. Ganss, E. Passegue, H. Song, S. Vandenberg, R.S. Johnson, Z. Werb, and G. Bergers HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell 13 2008 206 220
86. A.J. Maniotis, R. Folberg, A. Hess, E.A. Seftor, L.M. Gardner, J. Pe'er, J.M. Trent, P.S. Meltzer, and M.J. Hendrix Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am. J. Pathol. 155 1999 739 752
87. S. Zhang, H. Guo, D. Zhang, W. Zhang, X. Zhao, Z. Ren, and B. Sun Microcirculation patterns in different stages of melanoma growth Oncol. Rep. 15 2006 15 20
88. S. El Hallani, B. Boisselier, F. Peglion, A. Rousseau, C. Colin, A. Idbaih, Y. Marie, K. Mokhtari, J.L. Thomas, A. Eichmann, J.Y. Delattre, A.J. Maniotis, and M. Sanson A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry Brain 133 2010 973 982
89. X.M. Liu, Q.P. Zhang, Y.G. Mu, X.H. Zhang, K. Sai, J.C. Pang, H.K. Ng, and Z.P. Chen Clinical significance of vasculogenic mimicry in human gliomas J. Neurooncol. 105 2011 173 179
90. Y. Soda, T. Marumoto, D. Friedmann-Morvinski, M. Soda, F. Liu, H. Michiue, S. Pastorino, M. Yang, R.M. Hoffman, S. Kesari, and I.M. Verma Transdifferentiation of glioblastoma cells into vascular endothelial cells Proc. Natl. Acad. Sci. U. S. A. 108 2011 4274 4280
91. A.E. Wurmser, K. Nakashima, R.G. Summers, N. Toni, K.A. D'Amour, D.C. Lie, and F.H. Gage Cell fusion-independent differentiation of neural stem cells to the endothelial lineage Nature 430 2004 350 356
92. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
93. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
94. T. Morimura, C. Neuchrist, K. Kitz, H. Budka, O. Scheiner, D. Kraft, and H. Lassmann Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation Acta Neuropathol. 80 1990 287 294
95. I.F. Parney, J.S. Waldron, and A.T. Parsa Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation J. Neurosurg. 110 2009 572 582
96. W. Roggendorf, S. Strupp, and W. Paulus Distribution and characterization of microglia/macrophages in human brain tumors Acta Neuropathol. 92 1996 288 293
97. M.L. Rossi, N.R. Jones, E. Candy, J.A. Nicoll, J.S. Compton, J.T. Hughes, M.M. Esiri, T.H. Moss, F.F. Cruz-Sanchez, and H.B. Coakham The mononuclear cell infiltrate compared with survival in high-grade astrocytomas Acta Neuropathol. 78 1989 189 193
98. J.J. Watters, J.M. Schartner, and B. Badie Microglia function in brain tumors J. Neurosci. Res. 81 2005 447 455
99. L. Bingle, N.J. Brown, and C.E. Lewis The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J. Pathol. 196 2002 254 265
100. L. Yi, H. Xiao, M. Xu, X. Ye, J. Hu, F. Li, M. Li, C. Luo, S. Yu, X. Bian, and H. Feng Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma J. Neuroimmunol. 232 2011 75 82
101. S.C. Wang, J.H. Hong, C. Hsueh, and C.S. Chiang Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model Lab. Invest. 92 2012 151 162
102. M. Tafani, M. Di Vito, A. Frati, L. Pellegrini, E. De Santis, G. Sette, A. Eramo, P. Sale, E. Mari, A. Santoro, A. Raco, M. Salvati, R. De Maria, and M.A. Russo Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma J. Neuroinflammation 8 2011 32
103. K. Gabrusiewicz, A. Ellert-Miklaszewska, M. Lipko, M. Sielska, M. Frankowska, and B. Kaminska Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas PLoS One 6 2011 e23902
104. A. Wu, J. Wei, L.Y. Kong, Y. Wang, W. Priebe, W. Qiao, R. Sawaya, and A.B. Heimberger Glioma cancer stem cells induce immunosuppressive macrophages/microglia Neuro Oncol. 12 2010 1113 1125
105. A. Mantovani, and A. Sica Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr. Opin. Immunol. 22 2010 231 237
106. J. Wei, J. Barr, L.Y. Kong, Y. Wang, A. Wu, A.K. Sharma, J. Gumin, V. Henry, H. Colman, W. Priebe, R. Sawaya, F.F. Lang, and A.B. Heimberger Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway Mol. Cancer Ther. 9 2010 67 78
107. J.T. Jordan, W. Sun, S.F. Hussain, G. DeAngulo, S.S. Prabhu, and A.B. Heimberger Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy Cancer Immunol. Immunother. 57 2008 123 131
108. J. Wei, A. Wu, L.Y. Kong, Y. Wang, G. Fuller, I. Fokt, G. Melillo, W. Priebe, and A.B. Heimberger Hypoxia potentiates glioma-mediated immunosuppression PLoS One 6 2011 e16195
109. M. Abou-Ghazal, D.S. Yang, W. Qiao, C. Reina-Ortiz, J. Wei, L.Y. Kong, G.N. Fuller, N. Hiraoka, W. Priebe, R. Sawaya, and A.B. Heimberger The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas Clin. Cancer Res. 14 2008 8228 8235
110. O.A. Guryanova, Q. Wu, L. Cheng, J.D. Lathia, Z. Huang, J. Yang, J. MacSwords, C.E. Eyler, R.E. McLendon, J.M. Heddleston, W. Shou, D. Hambardzumyan, J. Lee, A.B. Hjelmeland, A.E. Sloan, M. Bredel, G.R. Stark, J.N. Rich, and S. Bao Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3 Cancer Cell 19 2011 498 511
111. M.M. Sherry, A. Reeves, J.K. Wu, and B.H. Cochran STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells Stem Cells 27 2009 2383 2392
112. C. Ginestier, S. Liu, M.E. Diebel, H. Korkaya, M. Luo, M. Brown, J. Wicinski, O. Cabaud, E. Charafe-Jauffret, D. Birnbaum, J.L. Guan, G. Dontu, and M.S. Wicha CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts J. Clin. Invest. 120 2010 485 497
113. E. Tartour, H. Pere, B. Maillere, M. Terme, N. Merillon, J. Taieb, F. Sandoval, F. Quintin-Colonna, K. Lacerda, A. Karadimou, C. Badoual, A. Tedgui, W.H. Fridman, and S. Oudard Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy Cancer Metastasis Rev. 30 2011 83 95
114. J.W. Tjiu, J.S. Chen, C.T. Shun, S.J. Lin, Y.H. Liao, C.Y. Chu, T.F. Tsai, H.C. Chiu, Y.S. Dai, H. Inoue, P.C. Yang, M.L. Kuo, and S.H. Jee Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction J. Invest. Dermatol. 129 2009 1016 1025
115. J.M. Weiss, L.A. Ridnour, T. Back, S.P. Hussain, P. He, A.E. Maciag, L.K. Keefer, W.J. Murphy, C.C. Harris, D.A. Wink, and R.H. Wiltrout Macrophage-dependent nitric oxide expression regulates tumor cell detachment and metastasis after IL-2/anti-CD40 immunotherapy J. Exp. Med. 207 2010 2455 2467
116. J. Anido, A. Saez-Borderias, A. Gonzalez-Junca, L. Rodon, G. Folch, M.A. Carmona, R.M. Prieto-Sanchez, I. Barba, E. Martinez-Saez, L. Prudkin, I. Cuartas, C. Raventos, F. Martinez-Ricarte, M.A. Poca, D. Garcia-Dorado, M.M. Lahn, J.M. Yingling, J. Rodon, J. Sahuquillo, J. Baselga, and J. Seoane TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma Cancer Cell 18 2010 655 668
117. M. Ehtesham, K.Y. Mapara, C.B. Stevenson, and R.C. Thompson CXCR4 mediates the proliferation of glioblastoma progenitor cells Cancer Lett. 274 2009 305 312
118. W. Loilome, A.D. Joshi, C.M. ap Rhys, S. Piccirillo, A.L. Vescovi, G.L. Gallia, and G.J. Riggins Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling J. Neurooncol. 94 2009 359 366
119. S. Peñuelas, J. Anido, R.M. Prieto-Sanchez, G. Folch, I. Barba, I. Cuartas, D. Garcia-Dorado, M.A. Poca, J. Sahuquillo, J. Baselga, and J. Seoane TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma Cancer Cell 15 2009 315 327
120. V. Nizet, and R.S. Johnson Interdependence of hypoxic and innate immune responses Nat. Rev. Immunol. 9 2009 609 617
121. E.P. Cummins, E. Berra, K.M. Comerford, A. Ginouves, K.T. Fitzgerald, F. Seeballuck, C. Godson, J.E. Nielsen, P. Moynagh, J. Pouyssegur, and C.T. Taylor Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity Proc. Natl. Acad. Sci. U. S. A. 103 2006 18154 18159
122. C.T. Taylor, and E.P. Cummins The role of NF-kappaB in hypoxia-induced gene expression Ann. N. Y. Acad. Sci. 1177 2009 178 184
123. M.A. Esteban, M.G. Tran, S.K. Harten, P. Hill, M.C. Castellanos, A. Chandra, R. Raval, T.S. O'Brien, and P.H. Maxwell Regulation of E-cadherin expression by VHL and hypoxia-inducible factor Cancer Res. 66 2006 3567 3575
124. A.J. Evans, R.C. Russell, O. Roche, T.N. Burry, J.E. Fish, V.W. Chow, W.Y. Kim, A. Saravanan, M.A. Maynard, M.L. Gervais, R.I. Sufan, A.M. Roberts, L.A. Wilson, M. Betten, C. Vandewalle, G. Berx, P.A. Marsden, M.S. Irwin, B.T. Teh, M.A. Jewett, and M. Ohh VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail Mol. Cell. Biol. 27 2007 157 169
125. B. Krishnamachary, D. Zagzag, H. Nagasawa, K. Rainey, H. Okuyama, J.H. Baek, and G.L. Semenza Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B Cancer Res. 66 2006 2725 2731
126. M.H. Yang, M.Z. Wu, S.H. Chiou, P.M. Chen, S.Y. Chang, C.J. Liu, S.C. Teng, and K.J. Wu Direct regulation of TWIST by HIF-1alpha promotes metastasis Nat. Cell Biol. 10 2008 295 305
127. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
128. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, A.L. Richardson, and R.A. Weinberg Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast Cell 145 2011 926 940
129. M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R.H. Datar, and R.J. Cote Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin. Cancer Res. 12 2006 5615 5621
130. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, M. Guba, C.J. Bruns, and C. Heeschen Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323
131. R. Pang, W.L. Law, A.C.Y. Chu, J.T. Poon, C.S.C. Lam, A.K.M. Chow, L. Ng, L.W.H. Cheung, X.R. Lan, H.Y. Lan, V.P.Y. Tan, T.C. Yau, R.T. Poon, and B.C.Y. Wong A subpopulation of CD26 + cancer stem cells with metastatic capacity in human colorectal cancer Cell Stem Cell 6 2010 603 615
132. F. Arai, and T. Suda Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche Ann. N. Y. Acad. Sci. 1106 2007 41 53
133. C. Lo Celso, H.E. Fleming, J.W. Wu, C.X. Zhao, S. Miake-Lye, J. Fujisaki, D. Cote, D.W. Rowe, C.P. Lin, and D.T. Scadden Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche Nature 457 2009 92 96
134. L.D. Wang, and A.J. Wagers Dynamic niches in the origination and differentiation of haematopoietic stem cells Nat. Rev. Mol. Cell Biol. 12 2011 643 655
135. Y. Xie, T. Yin, W. Wiegraebe, X.C. He, D. Miller, D. Stark, K. Perko, R. Alexander, J. Schwartz, J.C. Grindley, J. Park, J.S. Haug, J.P. Wunderlich, H. Li, S. Zhang, T. Johnson, R.A. Feldman, and L. Li Detection of functional haematopoietic stem cell niche using real-time imaging Nature 457 2009 97 101
136. E.E. Bar Glioblastoma, cancer stem cells and hypoxia Brain Pathol. 21 2011 119 129
137. S.J. Conley, E. Gheordunescu, P. Kakarala, B. Newman, H. Korkaya, A.N. Heath, S.G. Clouthier, and M.S. Wicha Antiangiogenic agents increase breast
138. M.J. Kiel, O.H. Yilmaz, T. Iwashita, C. Terhorst, and S.J. Morrison SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells Cell 121 2005 1109 1121
139. J.P. Levesque, and I.G. Winkler Hierarchy of immature hematopoietic cells related to blood flow and niche Curr. Opin. Hematol. 18 2011 220 225
140. K. Parmar, P. Mauch, J.A. Vergilio, R. Sackstein, and J.D. Down Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia Proc. Natl. Acad. Sci. U. S. A. 104 2007 5431 5436
141. H. Ohgaki, and P. Kleihues Genetic alterations and signaling pathways in the evolution of gliomas Cancer Sci. 100 2009 2235 2241
142. R.G. Verhaak, K.A. Hoadley, E. Purdom, V. Wang, Y. Qi, M.D. Wilkerson, C.R. Miller, L. Ding, T. Golub, J.P. Mesirov, G. Alexe, M. Lawrence, M. O'Kelly, P. Tamayo, B.A. Weir, S. Gabriel, W. Winckler, S. Gupta, L. Jakkula, H.S. Feiler, J.G. Hodgson, C.D. James, J.N. Sarkaria, C. Brennan, A. Kahn, P.T. Spellman, R.K. Wilson, T.P. Speed, J.W. Gray, M. Meyerson, G. Getz, C.M. Perou, and D.N. Hayes Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell 17 2010 98 110
143. H.S. Günther, N.O. Schmidt, H.S. Phillips, D. Kemming, S. Kharbanda, R. Soriano, Z. Modrusan, H. Meissner, M. Westphal, and K. Lamszus Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria Oncogene 27 2008 2897 2909
144. B. Das, R. Tsuchida, D. Malkin, G. Koren, S. Baruchel, and H. Yeger Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction Stem Cells 26 2008 1818 1830
145. H. Iida, M. Suzuki, R. Goitsuka, and H. Ueno Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2 Int. J. Oncol. 40 2012 71 79
146. Y. Ma, D. Liang, J. Liu, K. Axcrona, G. Kvalheim, T. Stokke, J.M. Nesland, and Z. Suo Prostate cancer cell lines under hypoxia exhibit greater stem-like properties PLoS One 6 2011 e29170
147. K. Takubo, and T. Suda Roles of the hypoxia response system in hematopoietic and leukemic stem cells Int. J. Hematol. 95 2012 478 483
148. F. Xing, H. Okuda, M. Watabe, A. Kobayashi, S.K. Pai, W. Liu, P.R. Pandey, K. Fukuda, S. Hirota, T. Sugai, G. Wakabayshi, K. Koeda, M. Kashiwaba, K. Suzuki, T. Chiba, M. Endo, Y.Y. Mo, and K. Watabe Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells Oncogene 30 2011 4075 4086
149. W. Zeng, R. Wan, Y. Zheng, S.R. Singh, and Y. Wei Hypoxia, stem cells and bone tumor Cancer Lett. 313 2011 129 136
150. B. Beck, G. Driessens, S. Goossens, K.K. Youssef, A. Kuchnio, A. Caauwe, P.A. Sotiropoulou, S. Loges, G. Lapouge, A. Candi, G. Mascre, B. Drogat, S. Dekoninck, J.J. Haigh, P. Carmeliet, and C. Blanpain A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours Nature 478 2011 399 403
151. M.S. Campos, K.G. Neiva, K.A. Meyers, S. Krishnamurthy, and J.E. Nor Endothelial derived factors inhibit anoikis of head and neck cancer stem cells Oral Oncol. 48 2012 26 32
152. S. Krishnamurthy, Z. Dong, D. Vodopyanov, A. Imai, J.I. Helman, M.E. Prince, M.S. Wicha, and J.E. Nor Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells Cancer Res. 70 2010 9969 9978
153. A. Pietras, D. Gisselsson, I. Ora, R. Noguera, S. Beckman, S. Navarro, and S. Pahlman High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche J. Pathol. 214 2008 482 488
154. D. Iliopoulos, H.A. Hirsch, G. Wang, and K. Struhl Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion Proc. Natl. Acad. Sci. U. S. A. 108 2011 1397 1402
155. M. Jinushi, M. Baghdadi, S. Chiba, and H. Yoshiyama Regulation of cancer stem cell activities by tumor-associated macrophages Am. J. Cancer Res. 2 2012 529 539
156. M. Jinushi, S. Chiba, H. Yoshiyama, K. Masutomi, I. Kinoshita, H. Dosaka-Akita, H. Yagita, A. Takaoka, and H. Tahara Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells Proc. Natl. Acad. Sci. U. S. A. 108 2011 12425 12430
157. H. Korkaya, S. Liu, and M.S. Wicha Breast cancer stem cells, cytokine networks, and the tumor microenvironment J. Clin. Invest. 121 2011 3804 3809
158. S.H. Lee, H.S. Hong, Z.X. Liu, R.H. Kim, M.K. Kang, N.H. Park, and K.H. Shin TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells Biochem. Biophys. Res. Commun. 424 2012 58 64
159. J.M. Ebos, and R.S. Kerbel Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Nat. Rev. Clin. Oncol. 8 2011 210 221
160. B.K. Garvalov, and T. Acker Cancer stem cells: a new framework for the design of tumor therapies J. Mol. Med. 89 2011 95 107
161. J. Lee, M.J. Son, K. Woolard, N.M. Donin, A. Li, C.H. Cheng, S. Kotliarova, Y. Kotliarov, J. Walling, S. Ahn, M. Kim, M. Totonchy, T. Cusack, C. Ene, H. Ma, Q. Su, J.C. Zenklusen, W. Zhang, D. Maric, and H.A. Fine Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells Cancer Cell 13 2008 69 80
162. S.G. Piccirillo, B.A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco, and A.L. Vescovi Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells Nature 444 2006 761 765
163. M.C. Assanah, J.N. Bruce, S.O. Suzuki, A. Chen, J.E. Goldman, and P. Canoll PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain Glia 57 2009 1835 1847
164. Y. Jiang, M. Boije, B. Westermark, and L. Uhrbom PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation Neoplasia 13 2011 492 503
165. M. Fareh, L. Turchi, V. Virolle, D. Debruyne, F. Almairac, S. de-la-Forest Divonne, P. Paquis, O. Preynat-Seauve, K.H. Krause, H. Chneiweiss, and T. Virolle The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network Cell Death Differ. 19 2012 232 244
166. M.H. Shahi, M. Afzal, S. Sinha, C.G. Eberhart, J.A. Rey, X. Fan, and J.S. Castresana Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma BMC Cancer 10 2010 614
167. H. Uchida, K. Arita, S. Yunoue, H. Yonezawa, Y. Shinsato, H. Kawano, H. Hirano, R. Hanaya, and H. Tokimura Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells J. Neurooncol. 104 2011 697 704
168. M. Zbinden, A. Duquet, A. Lorente-Trigos, S.N. Ngwabyt, I. Borges, and A. Ruiz i Altaba, NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53 EMBO J. 29 2010 2659 2674
169. A. Bruna, R.S. Darken, F. Rojo, A. Ocana, S. Penuelas, A. Arias, R. Paris, A. Tortosa, J. Mora, J. Baselga, and J. Seoane High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene Cancer Cell 11 2007 147 160
170. H. Ikushima, T. Todo, Y. Ino, M. Takahashi, K. Miyazawa, and K. Miyazono Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors Cell Stem Cell 5 2009 504 514
171. I. Augustin, V. Goidts, A. Bongers, G. Kerr, G. Vollert, B. Radlwimmer, C. Hartmann, C. Herold-Mende, G. Reifenberger, A. von Deimling, and M. Boutros The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis EMBO Mol. Med. 4 2012 38 51
172. T. Pulvirenti, M. Van Der Heijden, L.A. Droms, J.T. Huse, V. Tabar, and A. Hall Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas Cancer Res. 71 2011 7280 7290
173. M. Rossi, L. Magnoni, C. Miracco, E. Mori, P. Tosi, L. Pirtoli, P. Tini, G. Oliveri, E. Cosci, and A. Bakker beta-catenin and Gli1 are prognostic markers in glioblastoma Cancer Biol. Ther. 11 2011 753 761
174. N. Zhang, P. Wei, A. Gong, W.T. Chiu, H.T. Lee, H. Colman, H. Huang, J. Xue, M. Liu, Y. Wang, R. Sawaya, K. Xie, W.K. Yung, R.H. Medema, X. He, and S. Huang FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis Cancer Cell 20 2011 427 442
175. H. Zheng, H. Ying, R. Wiedemeyer, H. Yan, S.N. Quayle, E.V. Ivanova, J.H. Paik, H. Zhang, Y. Xiao, S.R. Perry, J. Hu, A. Vinjamoori, B. Gan, E. Sahin, M.G. Chheda, C. Brennan, Y.A. Wang, W.C. Hahn, L. Chin, and R.A. DePinho PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas Cancer Cell 17 2010 497 509
176. Y.Y. Hu, M.H. Zheng, G. Cheng, L. Li, L. Liang, F. Gao, Y.N. Wei, L.A. Fu, and H. Han Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells BMC Cancer 11 2011 82
177. B.W. Purow, R.M. Haque, M.W. Noel, Q. Su, M.J. Burdick, J. Lee, T. Sundaresan, S. Pastorino, J.K. Park, I. Mikolaenko, D. Maric, C.G. Eberhart, and H.A. Fine Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation Cancer Res. 65 2005 2353 2363
178. A.H. Shih, and E.C. Holland Notch signaling enhances nestin expression in gliomas Neoplasia 8 2006 1072 1082
179. J. Wang, T.P. Wakeman, J.D. Lathia, A.B. Hjelmeland, X.F. Wang, R.R. White, J.N. Rich, and B.A. Sullenger Notch promotes radioresistance of glioma stem cells Stem Cells 28 2010 17 28
180. X.P. Zhang, G. Zheng, L. Zou, H.L. Liu, L.H. Hou, P. Zhou, D.D. Yin, Q.J. Zheng, L. Liang, S.Z. Zhang, L. Feng, L.B. Yao, A.G. Yang, H. Han, and J.Y. Chen Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells Mol. Cell. Biochem. 307 2008 101 108
181. K.M. Joo, J. Jin, E. Kim, K. Ho Kim, Y. Kim, B. Gu Kang, Y.J. Kang, J.D. Lathia, K. Ho Cheong, P.H. Song, H. Kim, H.J. Seol, D.S. Kong, J.I. Lee, J.N. Rich, J. Lee, and D.H. Nam MET signaling regulates glioblastoma stem cells Cancer Res. 72 2012 3828 3838
182. S.E. Kendall, J. Najbauer, H.F. Johnston, M.Z. Metz, S. Li, M. Bowers, E. Garcia, S.U. Kim, M.E. Barish, K.S. Aboody, and C.A. Glackin Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling Stem Cells 26 2008 1575 1586
183. Y. Li, A. Li, M. Glas, B. Lal, M. Ying, Y. Sang, S. Xia, D. Trageser, H. Guerrero-Cazares, C.G. Eberhart, A. Quinones-Hinojosa, B. Scheffler, and J. Laterra c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype Proc. Natl. Acad. Sci. U. S. A. 108 2011 9951 9956
184. R. Bonavia, M.M. Inda, S. Vandenberg, S.Y. Cheng, M. Nagane, P. Hadwiger, P. Tan, D.W. Sah, W.K. Cavenee, and F.B. Furnari EGFRvIII promotes glioma angiogenesis and growth through the NF-kappaB, interleukin-8 pathway Oncogene 2011
185. F. Griffero, A. Daga, D. Marubbi, M.C. Capra, A. Melotti, A. Pattarozzi, M. Gatti, A. Bajetto, C. Porcile, F. Barbieri, R.E. Favoni, M. Lo Casto, G. Zona, R. Spaziante, T. Florio, and G. Corte Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors J. Biol. Chem. 284 2009 7138 7148
186. X. Jin, J. Yin, S.H. Kim, Y.W. Sohn, S. Beck, Y.C. Lim, D.H. Nam, Y.J. Choi, and H. Kim EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction Cancer Res. 71 2011 7125 7134
187. L. Li, A. Dutra, E. Pak, J.E. Labrie III, R.M. Gerstein, P.P. Pandolfi, L.D. Recht, and A.H. Ross EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors Neuro Oncol. 11 2009 9 21
188. S. Mazzoleni, L.S. Politi, M. Pala, M. Cominelli, A. Franzin, L. Sergi Sergi, A. Falini, M. De Palma, A. Bulfone, P.L. Poliani, and R. Galli Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis Cancer Res. 70 2010 7500 7513
189. M. Nagane, F. Coufal, H. Lin, O. Bogler, W.K. Cavenee, and H.J. Huang A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis Cancer Res. 56 1996 5079 5086
190. Y. Cao, J.D. Lathia, C.E. Eyler, Q. Wu, Z. Li, H. Wang, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance Genes Cancer 1 2010 50 61
191. H. Wang, J.D. Lathia, Q. Wu, J. Wang, Z. Li, J.M. Heddleston, C.E. Eyler, J. Elderbroom, J. Gallagher, J. Schuschu, J. MacSwords, Y. Cao, R.E. McLendon, X.F. Wang, A.B. Hjelmeland, and J.N. Rich Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth Stem Cells 27 2009 2393 2404
192. S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Targeting cancer stem cells through L1CAM suppresses glioma growth Cancer Res. 68 2008 6043 6048
193. Y. Kim, E. Kim, Q. Wu, O. Guryanova, M. Hitomi, J.D. Lathia, D. Serwanski, A.E. Sloan, R.J. Weil, J. Lee, A. Nishiyama, S. Bao, A.B. Hjelmeland, and J.N. Rich Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity Genes Dev. 26 2012 1247 1262
194. A.B. Hjelmeland, Q. Wu, S. Wickman, C. Eyler, J. Heddleston, Q. Shi, J.D. Lathia, J. Macswords, J. Lee, R.E. McLendon, and J.N. Rich Targeting A20 decreases glioma stem cell survival and tumor growth PLoS Biol. 8 2010 e1000319
195. C.E. Eyler, W.C. Foo, K.M. LaFiura, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Brain cancer stem cells display preferential sensitivity to Akt inhibition Stem Cells 26 2008 3027 3036
196. G.L. Gallia, B.M. Tyler, C.L. Hann, I.M. Siu, V.L. Giranda, A.L. Vescovi, H. Brem, and G.J. Riggins Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells Mol. Cancer Ther. 8 2009 386 393
197. J.R. Molina, Y. Hayashi, C. Stephens, and M.M. Georgescu Invasive glioblastoma cells acquire stemness and increased Akt activation Neoplasia 12 2010 453 463
198. D. Hsieh, A. Hsieh, B. Stea, and R. Ellsworth IGFBP2 promotes glioma tumor stem cell expansion and survival Biochem. Biophys. Res. Commun. 397 2010 367 372
199. E.M. Galan-Moya, A. Le Guelte, E. Lima Fernandes, C. Thirant, J. Dwyer, N. Bidere, P.O. Couraud, M.G. Scott, M.P. Junier, H. Chneiweiss, and J. Gavard Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway EMBO Rep. 12 2011 470 476
200. C.H. Yoon, K.H. Hyun, R.K. Kim, H. Lee, E.J. Lim, H.Y. Chung, S. An, M.J. Park, Y. Suh, M.J. Kim, and S.J. Lee The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells FEBS Lett. 585 2011 2331 2338
201. B. Kefas, J. Godlewski, L. Comeau, Y. Li, R. Abounader, M. Hawkinson, J. Lee, H. Fine, E.A. Chiocca, S. Lawler, and B. Purow microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma Cancer Res. 68 2008 3566 3572
202. F. Guessous, Y. Zhang, A. Kofman, A. Catania, Y. Li, D. Schiff, B. Purow, and R. Abounader microRNA-34a is tumor suppressive in brain tumors and glioma stem cells Cell Cycle 9 2010 1031 1036
203. Y. Li, F. Guessous, Y. Zhang, C. Dipierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T.D. Schmittgen, B. Lopes, D. Schiff, B. Purow, and R. Abounader MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes Cancer Res. 69 2009 7569 7576
204. J. Godlewski, M.O. Nowicki, A. Bronisz, S. Williams, A. Otsuki, G. Nuovo, A. Raychaudhury, H.B. Newton, E.A. Chiocca, and S. Lawler Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal Cancer Res. 68 2008 9125 9130
205. B. Kefas, L. Comeau, D.H. Floyd, O. Seleverstov, J. Godlewski, T. Schmittgen, J. Jiang, C.G. diPierro, Y. Li, E.A. Chiocca, J. Lee, H. Fine, R. Abounader, S. Lawler, and B. Purow The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors J. Neurosci. 29 2009 15161 15168
206. H. Gal, G. Pandi, A.A. Kanner, Z. Ram, G. Lithwick-Yanai, N. Amariglio, G. Rechavi, and D. Givol MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells Biochem. Biophys. Res. Commun. 376 2008 86 90
207. S.W. Bruggeman, D. Hulsman, E. Tanger, T. Buckle, M. Blom, J. Zevenhoven, O. van Tellingen, and M. van Lohuizen Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma Cancer Cell 12 2007 328 341
208. S. Facchino, M. Abdouh, W. Chatoo, and G. Bernier BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery J. Neurosci. 30 2010 10096 10111
209. J. Wang, H. Wang, Z. Li, Q. Wu, J.D. Lathia, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich c-Myc is required for maintenance of glioma cancer stem cells PLoS One 3 2008 e3769
210. H. Zheng, H. Ying, H. Yan, A.C. Kimmelman, D.J. Hiller, A.J. Chen, S.R. Perry, G. Tonon, G.C. Chu, Z. Ding, J.M. Stommel, K.L. Dunn, R. Wiedemeyer, M.J. You, C. Brennan, Y.A. Wang, K.L. Ligon, W.H. Wong, L. Chin, and R.A. dePinho Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma Cold Spring Harb. Symp. Quant. Biol. 73 2008 427 437
211. G.H. Li, H. Wei, S.Q. Lv, H. Ji, and D.L. Wang Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells Int. J. Oncol. 37 2010 103 110